Boxed warning suicidal thoughts and behaviors: Bupropion, one of the two active ingredients in Contrave, carries an FDA boxed warning about increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (under 25) taking antidepressants
It is not yet FDA-approved but has shown remarkable weight loss results in phase 2 trials, with participants losing up to 24.2% of body weight at the highest dose over 48 weeks
Additionally, withdrawal symptoms like increased appetite, binge eating, and blood sugar spikes in diabetic patients can make the transition even more challenging
Additional studies have explored activation of focal adhesion kinase (FAK) and paxillin pathways in fibroblasts, which are involved in cellular migration, extracellular matrix interactions, and structural tissue dynamics [2]
adults in English and in Spanish